Therapy for treatment-refractory chronic Hepatitis C virus genotype 1b infection: A retrospective analysis

Creative Commons License

Cindoruk M., Karakan T., ÜNAL S.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, vol.66, no.5, pp.451-462, 2005 (SCI-Expanded) identifier identifier identifier


Background: The most effective current therapy for hepatitis C virus (HCV) infection is the combination of pegylated interferon (peg-IFN) plus ribavirin (RBV).